TELA Bio Introduces LIQUIFIX for Internal Use in Hernia Surgery Across the US
Shots:
- TELA Bio has launched the LIQUIFIX FIX8 Laparoscopic device, designed for minimally invasive femoral and inguinal hernia repairs as well as the LIQUIFIX Precision Open Hernia Mesh Fixation device, developed for open femoral and inguinal hernia repairs, across the US
- LIQUIFIX hernia mesh fixation devices utilize liquid adhesive that minimizes the necessity to penetrate mechanical tacks, sutures, or staples thus reducing the risk of tissue trauma along with providing precise & controlled mesh fixation
- In 2023, Advanced Medical Solutions partnered with TELA Bio to commercialize LIQUIFIX products by utilizing TELA Bio's hernia repair specialty salesforce across the US
Ref: TELA Bio | Image: TELA Bio
Realated News:- TELA Bio's Restella Reconstructive BioScaffolds Receives FDA's 510(k) Clearance for Reconstructive Surgery
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
